Fosfomycin is a well-known antibiotic that exhibits broad-spectrum activity against various bacterial pathogens, including gram-negative strains and some gram-positive strains such as staphylococci. The use of parenteral fosfomycin has been recently revised because the antibiotic has been found to effectively manage serious infections caused by multidrug-resistant pathogens. The occurrence of fosfomycin resistance could threaten the reintroduction of this antibiotic for the treatment of bacterial infections. In this study, a total of 24 fosfomycin-resistant Escherichia coli isolates obtained from urine samples were used to investigate the prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes. The replication origins of the conjugative and transformant plasmids obtained from the isolates were examined using the replication origin determination method based on the polymerase chain reaction (PCR). Through the PCR process performed with the fosA, fosA3, fosB, fosC, fosC2, and fosX genes to determine fosfomycin resistance, one out of 24 samples was found to be fosA3 gene-positive. A Class-1 integron gene was detected in three fosfomycin-resistant E. coli isolates, while no Class-2 integrons were detected in any isolate. The conjugation experiments demonstrated that the fosA3 gene was transferable in one isolate that also carried the blaTEM, blaCTX-M-15, and aac(6')-ib-cr genes. Through plasmid isolation in the transconjugant E. coli isolates, it was determined that the E. coli isolate FF21 carried fosfomycin resistance on the plasmid. To ensure the continued effective use of fosfomycin as a treatment option, fosfomycin resistance needs to be detected and closely monitored. Given the global rise in plasmid-transmissible genes, we anticipate a growing resistance to fosfomycin in the near future.

Department of Medical Biology and Genetics Ahi Evran University School of Medicine Kirsehir Turkey

Department of Medical Microbiology Amasya University School of Medicine Amasya 05100 Turkey

Department of Molecular Medicine Kirsehir Ahi Evran University Health Sciences Institute Kirsehir Turkey

Zobrazit více v PubMed

Alpay-Karaoglu S, Ozgumus OB, Sevim E, Kolaylı F, Sevim A, Yesilgil P (2007) Investigation of antibiotic resistance profile and TEM-type β-lactamase gene carriage of ampicillin-resistant Escherichia coli strains isolated from drinking water. Ann Microbiol 57:281–288. https://doi.org/10.1007/BF03175221 DOI

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410. https://doi.org/10.1016/S0022-2836(05)80360-2 PubMed DOI

Baylan O (2010) Fosfomycin: past, present and future. Mikrobiyol Bul 44:311–321 PubMed

Benzerara Y, Gallah S, Hommeril B, Genel N, Decre D, Rottman M, Arlet G (2017) Emergence of plasmid-mediated fosfomycin-resistance genes among Escherichia coli isolates. France Emerg Infect Dis 23(9):1564–1567. https://doi.org/10.3201/eid2309.170560 PubMed DOI

Bi W, Li B, Song J, Zhang X, Liu H, Lu H, Zhou T, Cao J (2017) Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum b-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China. Int J Antimicrob Agents 50:29–34. https://doi.org/10.1016/j.ijantimicag.2017.02.010 PubMed DOI

Cao XL, Shen H, Xu YY, Xu XJ, Zhang ZF, Cheng L, Chen J-H, Arakawa Y (2017) High prevalence of fosfomycin resistance gene fosA3 in blaCTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010–2014. Epidemiol Infect 45:818–824. https://doi.org/10.1017/S0950268816002879 DOI

Cattoir V, Guérin F (2018) How is fosfomycin resistance developed in Escherichia coli? Future Microbiol 13(16):1693–1696. https://doi.org/10.2217/fmb-2018-0294 PubMed DOI

Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63(3):219–228. https://doi.org/10.1016/j.mimet.2005.03.018 PubMed DOI

Castaneda-Garcia A, Blazquez J, Rodriguez-Rojas A (2013) Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics (Basel) 2:217–236. https://doi.org/10.3390/antibiotics2020217 PubMed DOI

Díez-Aguilar M, Cantón R (2019) New microbiological aspects of fosfomycin. Rev Esp Quimioter 32(Suppl 1):8–18 PubMed PMC

The European Committee on Antimicrobial Susceptibility Testing (2019) Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0. http:// www. eucast. org. Accessed 9.12.2019

Falagas ME, Athanasaki F, Voulgaris GL, Triarides NA, Vardakas KZ (2019) Resistance to fosfomycin: mechanisms, frequency and clinical consequences. Int J Antimicrob Agents 53:22–28. https://doi.org/10.1016/j.ijantimicag.2018.09.013 PubMed DOI

Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10:43–50. https://doi.org/10.1016/S1473-3099(09)70325-1 PubMed DOI

Ho PL, Chan J, Lo WU, Lai EL, Cheung YY, Lau TC, Chow KH (2013) Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol 62:1707–1713. https://doi.org/10.1099/jmm.0.062653-0 PubMed DOI

Hou J, Yang X, Zeng Z, Lv L, Yang T, Lin D, Liu JH (2013) Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin. J Antimicrob Chemother 68:766–770. https://doi.org/10.1093/jac/dks465 PubMed DOI

Jiang W, Men S, Kong L, Ma S, Yang Y, Wang Y, Yuan Q, Cheng G, Zou W, Wang H (2017) Prevalence of plasmid mediated fosfomycin resistance gene fosA3 among CTX-M-producing Escherichia coli isolates from chickens in China. Foodborne Pathog Dis 14(4):210–218. https://doi.org/10.1089/fpd.2016.2230 PubMed DOI

Jiang Y, Shen P, Wei Z, Liu L, He F, Shi K, Wang Y, Wang H, Yu Y (2015) Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China. Int J Antimicrob Agents 45:66–70. https://doi.org/10.1016/j.ijantimicag.2014.08.010 PubMed DOI

Koken G, Asık G, Ciftci IH, Cetinkaya Z, Aktepe OC, Yılmazer M (2008) Efficiency of fosfomycin trometamol on Escherichia coli strains from community acquired urinary tract infections. ANKEM 22:23–27

Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35(6):1547–1549. https://doi.org/10.1093/molbev/msy096 PubMed DOI PMC

Lee JC, Lee NY, Lee HC, Huang WH, Tsui KC, Chang CM, Lee CC, Chen PL, Wu CJ, Hsueh PR, Ko WC (2012a) Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae and their emergence in the community. J Microbiol Immunol Infect 45:127–133. https://doi.org/10.1016/j.jmii.2011.09.029 PubMed DOI

Lee S-Y, Park Y-J, Yu JK, Jung S, Kim Y, Jeong SH, Arakawa Y (2012b) Prevalence of acquired fosfomycin resistance among extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS 26-composite transposon surrounding fosA3. J Antimicrob Chemother 67:2843–2847. https://doi.org/10.1093/jac/dks319 PubMed DOI

Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ (2011) Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect 44:364–368. https://doi.org/10.1016/j.jmii.2010.08.012 PubMed DOI

Martín-Gutiérrez G, Docobo-Pérez F, Rodriguez-Beltrán J, Rodríguez-Martínez JM, Aznar J, Pascual A, Blázquez J (2018) Urinary tract conditions affect fosfomycin activity against Escherichia coli strains harboring chromosomal mutations involved in fosfomycin uptake. Antimicrob Agents Chemother 62:e01899-e1917. https://doi.org/10.1128/AAC.01899-17 PubMed DOI

Neuzillet Y, Naber KG, Schito G, Gualco L, Botto H (2012) French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy. Me´d Mal Infect 42:66–75 PubMed DOI

Nigiz Ş, Hazırolan G, Köseoglu Eser Ö, Gür D (2022) First detection of Klebsiella pneumoniae isolate Co-harboring fosfomycin resistance gene fosA3 and bla ctx-m among gram negative urine isolates in a Turkish hospital. Microb Drug Resist 28(3):317–321. https://doi.org/10.1089/mdr.2021.0114 PubMed DOI

Oliveira PH, Prather KJ, Prazeres DM, Monteiro GA (2009) Structural instability of plasmid biopharmaceuticals: challenges and implications. Trends Biotechnol 27(9):503–511. https://doi.org/10.1016/j.tibtech.2009.06.004 PubMed DOI

Patwardhan V, Kumar D, Goel V, Singh S (2017) Changing prevalence and antibiotic drug resistance pattern of pathogens seen in community-acquired pediatric urinary tract infections at a tertiary care hospital of North India. J Lab Physicians 9(4):264–268. https://doi.org/10.4103/JLP.JLP_149_16 PubMed DOI PMC

Queipo-Ortuño Ml, Colmenero JDD, Macias M, Bravo MJ, Morata P (2008) Preparation of bacterial DNA template by boiling and effect of immunoglobulin G as an inhibitor in real-time PCR for serum samples from patients with brucellosis. Clin Vaccine Immunol 15(2):293–296. https://doi.org/10.1128/CVI.00270-07 PubMed DOI

Rozwandowicz M, Brouwer MSM, Fischer J, Wagenaar JA, Gonzalez-Zorn B, Guerra B, Mevius DJ, Hordijk J (2018) Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother 73(5):1121–1137. https://doi.org/10.1093/jac/dkx488 PubMed DOI

Sato N, Kawamura K, Nakane K, Wachino J, Arakawa Y (2013) First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan. Microb Drug Resist 19:477–482. https://doi.org/10.1089/mdr.2013.0061 PubMed DOI

Villa L, Garcia-Fernandez A, Fortini D, Carattoli A (2010) Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 65(12):2518–2529. https://doi.org/10.1093/jac/dkq347 PubMed DOI

Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y (2010) Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother 54:3061–3064. https://doi.org/10.1128/AAC.01834-09 PubMed DOI PMC

Wang Y, Lo WU, Lai EL, Chow KH, Ho PL (2015) Complete sequence of the multidrug-resistant IncL/M plasmid pIMP-HB623 cocarrying blaIMP-34 and fosC2 in an Enterobacter cloacae strain associated with medical travel to China. Antimicrob Agents Chemother 59:5854–6586. https://doi.org/10.1128/aac.00375-15 PubMed DOI PMC

Wang H, Min C, Li J, Yu T, Hu Y, Dou Q, Zou M (2021) Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China. BMC Microbiol 21(1):1–8. https://doi.org/10.1186/s12866-021-02165-7 DOI

White BP, Stover KR, Barber KE, Galloway RC, Sullivan DC, King ST (2017) Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp. Int J Antimicrob Agents 50:690–692. https://doi.org/10.1016/j.ijantimicag.2017.05.010 PubMed DOI

Yang TY, Lu PL, T SP, (2019) Update on fosfomycin-modified genes in Enterobacteriaceae. J Microbiol Immunol Infect 52:9–21. https://doi.org/10.1016/j.jmii.2017.10.006 PubMed DOI

Yao H, Dongfang W, Lei L, Shen Z, Wang Y, Liao K (2016) The detection of fosfomycin resistance genes in Enterobacteriaceae from pets and their owners. Vet Microbiol 193:67–71. https://doi.org/10.1016/j.vetmic.2016.07.019 PubMed DOI

Zurfluh K, Treier A, Schmitt K, Stephan R (2020) Mobile fosfomycin resistance genes in Enterobacteriaceae-an increasing threat. Microbiologyopen 9(12):e1135. https://doi.org/10.1002/mbo3.1135 PubMed DOI PMC